Overview
- Provides comprehensive coverage of all core aspects of clinical lipidology as well as relevant basic science and dyslipidemia management strategies
- Updated to include new guidelines, novel therapeutic agents, and changes in the understanding of specific lipids/lipoproteins and cardiovascular disease risk
- Highlights recent advances in the field such as novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, as well as imaging technologies and lipoprotein separation/measurement methodologies
Part of the book series: Contemporary Cardiology (CONCARD)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (35 chapters)
-
Front Matter
Keywords
- Atherosclerosis and lipidology
- Cardiometabolic disease and lipidology
- Cholesterol management
- Clinical lipidology
- Diabetes mellitus
- Hypercholesterolemia
- Imaging and lipidology
- Inflammatory disorders and lipidology
- Lipid disorders
- Lipids and lipoproteins
- Lipidology and the micobiome
- PCSK9 inhibitors and lipidology
- pharmacotherapy
About this book
The second edition of this important book provides an up-to-date and comprehensive overview of clinical lipidology. Brand new chapters focus on recent advances in the field including novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, imaging technologies, and epidemiology of atherosclerotic cardiovascular disease.
The book describes new guidelines, novel therapeutic agents, and changes in the understanding of specific lipoproteins and subclasses with regard to their relationships to cardiovascular disease risk. The second edition contains more than thirty chapters covering such topics as the history of lipidology, lipoprotein metabolism and vascular biology, disorders of lipid metabolism, lifestyle/dietary and pharmacologic management for dyslipidemia, the management of dyslipidemia in certain subgroups (e.g., women, children, older patients) and lipid testing, as well as an examination of other biomarkers and testing procedures related toatherosclerosis and cardiovascular disease.
The second edition of Therapeutic Lipidology is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.
Reviews
Editors and Affiliations
About the editors
The University of Chicago Pritzker School of Medicine
mdavidso@bsd.uchicago.edu
Peter P. Toth, MD, PhD
Director of Preventative Cardiology, CGH Medical Center
Professor of Clinical Family and Community Medicine, University of Illinois College of Medicine
Professor of Clinical Medicine, Michigan State University College of Osteopathic Medicine
Adjunct Associate Professor of Medicine, Johns Hopkins University School of Medicine
peter.toth@cghmc.com
Kevin C. Maki, PhD
President and Chief Scientist
Midwest Biomedical Research: Center for Metabolic & Cardiovascular Health
kmaki@mbclinicalresearch.com
Bibliographic Information
Book Title: Therapeutic Lipidology
Editors: Michael H. Davidson, Peter P. Toth, Kevin C. Maki
Series Title: Contemporary Cardiology
DOI: https://doi.org/10.1007/978-3-030-56514-5
Publisher: Humana Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Nature Switzerland AG 2021
Hardcover ISBN: 978-3-030-56513-8Published: 16 December 2020
Softcover ISBN: 978-3-030-56516-9Published: 17 December 2021
eBook ISBN: 978-3-030-56514-5Published: 15 December 2020
Series ISSN: 2196-8969
Series E-ISSN: 2196-8977
Edition Number: 2
Number of Pages: XV, 689
Number of Illustrations: 26 b/w illustrations, 114 illustrations in colour
Topics: Cardiology, Endocrinology, Pharmacotherapy